Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Publication year range
1.
Talanta ; 76(3): 580-90, 2008 Jul 30.
Article in English | MEDLINE | ID: mdl-18585324

ABSTRACT

Comparability of monitoring data are essential for any meaningful assessment and for the management of environmental risks of emerging pollutants. The reliability and comparability of data at European level is often limited, because analytical methods for emerging pollutants are often not fully validated, not harmonized or not suitable for all relevant matrices. This paper describes a collaborative interlaboratory exercise for the analysis of non-steroidal anti-inflammatory drugs (NSAIDs) residues in freshwater and wastewater, held in the framework of the EU project "Network of reference laboratories for monitoring of emerging environmental pollutants" (NORMAN). The NSAID compounds selected in this study were ketoprofen, naproxen, ibuprofen and diclofenac. Thirteen laboratories distributed along nine European Countries (Austria, France, Germany, Greece, Italy, Slovak Republic, Slovenia, Spain, and Switzerland) took part in this exercise, 126 samples were analyzed and a total number of 473 values in duplicate were collected. Samples selected in this study include environmental water (river water and waste water) and artificial water (fortified environmental and distilled water) with different ranges of complexity. Two analytical methods were proposed by the organiser; one is based on the use of solid phase extraction (SPE) followed by liquid chromatography-tandem mass spectrometry (LC-MS/MS) and the second one is based on SPE followed by gas-chromatography-mass spectrometry (GC-MS), however, in the first round some different approaches were also admitted. The main goals of this interlaboratory comparison were to evaluate the available analytical schemes for NSAID analysis in natural waters, to evaluate the repeatability (r) and reproducibility (R) between participating laboratories, and to evaluate the influence of the analytical method and sample matrices on the results.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/analysis , Gas Chromatography-Mass Spectrometry/standards , Tandem Mass Spectrometry/standards , Water Pollutants, Chemical/analysis , Chromatography, Liquid , Europe , Observer Variation , Reproducibility of Results , Solid Phase Extraction
3.
Minerva Med ; 82(12): 877-80, 1991 Dec.
Article in Italian | MEDLINE | ID: mdl-1780097

ABSTRACT

The paper reports a recently observed case of a 76-year-old man suffering from claudication of the upper limbs, undetectable brachial pressure and bilateral absence of radial, brachial and axillary pulses. During the previous two years the patient had complained of symptoms reminiscent of polymyalgia rheumatica. On admission to hospital, he also presented elevated ESR without temporal arteritic symptoms or involvement of other arterial districts, excluding the main supra-aortic branches, and without ocular signs. Arteriography showed the typical radiological findings of arteritis with bilateral occlusion of the subclavian arteries. Steroid therapy, which was commenced without previous histological biopsy, resulted in a clear subjective and objective improvement in the patient's condition. Following a review of the literature, the A. focus on the incidence of extra-temporal localisations of arteritis associated with polymyalgia rheumatica and on other related problems. They emphasise the importance of beginning steroid therapy as early as possible.


Subject(s)
Aortic Arch Syndromes/complications , Polymyalgia Rheumatica/complications , Aged , Humans , Male
5.
J Hypertens ; 1(3): 215-9, 1983 Oct.
Article in English | MEDLINE | ID: mdl-6241622

ABSTRACT

We have studied the effect of blood pressure control upon left ventricular mass and function. Twenty hypertensive patients without clinical or electrocardiographic signs of cardiac involvement were given sequentially: placebo for two weeks; captopril (250 mg/day) for eight weeks; and captopril (125 mg/day), alone or combined with chlorthalidone (25 mg/day), for eight weeks. M-mode echocardiography was performed at the end of placebo period, after eight and after 16 weeks active treatment. Blood pressure was significantly reduced (p less than 0.01) by therapy, the maximum decrease being observed at the end of the study. Similarly, interventricular septal thickness, posterior wall thickness and left ventricular mass index showed a significant reduction (P less than 0.01 at the eighth and P less than 0.001 at the 16th week), while no changes were detected in left ventricular function. Furthermore, both wall stress index at end-diastole and end-systolic stress were significantly lowered by treatment (at the 16th week P less than 0.01 and P less than 0.001, respectively). Baseline systolic blood pressure was inversely correlated with the ratio of the left ventricular radius to posterior wall thickness (r = -0.97, P less than 0.001) but no relation was found between post-treatment fall in either systolic or diastolic blood pressure and left ventricular mass index. After treatment more patients showed normal left ventricular wall thickness in relation to systolic blood pressure. We conclude that in uncomplicated hypertensive patients captopril, either alone or combined with chlorthalidone, can reverse left ventricular hypertrophy by decreasing both septal and posterior wall thickness.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Captopril/therapeutic use , Cardiomegaly/chemically induced , Hypertension/drug therapy , Proline/analogs & derivatives , Adult , Cardiomegaly/drug therapy , Cardiomegaly/pathology , Chlorthalidone/therapeutic use , Drug Therapy, Combination , Echocardiography , Female , Heart Rate/drug effects , Heart Ventricles/anatomy & histology , Heart Ventricles/drug effects , Heart Ventricles/physiopathology , Humans , Male , Middle Aged
SELECTION OF CITATIONS
SEARCH DETAIL
...